Women’s Fertility Care at Follicles, Sector 10, Noida
Understanding First, Treatment Second
Female infertility treatment in Noida, built on evaluation, not assumptions.
Ovulation, ovarian reserve, tubes and uterus, assessed as one picture.
Consult Dr. Shuchi Rastogi, IVF & Infertility Specialist.
Female infertility means difficulty achieving pregnancy related to factors affecting the female reproductive system, such as ovulation problems, ovarian reserve and egg quality, blocked fallopian tubes, uterine conditions or age related changes. Infertility can involve female factors, male factors, both together or no identifiable cause at all, which is why evaluation usually covers both partners rather than assuming the cause lies with the woman.
The reasons for female infertility can vary from one person to another, and more than one factor may contribute. A fertility specialist may review menstrual history, previous pregnancies, medical conditions and how long you have been trying to conceive. Depending on your circumstances, investigations may include hormone testing, ultrasound scans or assessment of the fallopian tubes. These findings help guide decisions about appropriate fertility treatment and whether further evaluation is needed. With an individual assessment, you can better understand your options and discuss the next steps with your specialist.
Problems with regular ovulation are among the most common causes of female infertility. If an egg is not released, or is released irregularly, conception becomes harder to achieve and harder to time. Irregular or absent ovulation can occur for different reasons, which is why it is investigated rather than assumed.
PCOS is one of the more frequent contributors to ovulation problems. It can be associated with irregular or absent ovulation, which may make conception more difficult for some women. PCOS affects individuals very differently, and many women with PCOS conceive, with or without treatment.
Ovarian reserve describes the quantity of eggs remaining in the ovaries. It is relevant to fertility treatment planning, particularly to how the ovaries may respond to stimulation. Importantly, ovarian reserve on its own does not predict natural fertility for every woman, a distinction explained further below.
Female fertility generally declines with age, as both egg quantity and egg quality change over time. Age is one of the most important factors in any fertility assessment, and it shapes how quickly evaluation and treatment decisions are made.
The fallopian tubes are where egg and sperm meet. Blocked or damaged tubes, whether from previous pelvic infection, endometriosis, surgery or other causes, can prevent that meeting and are a well recognised cause of infertility.
Endometriosis, where tissue similar to the uterine lining grows outside the uterus, can be associated with infertility. Its impact varies widely between individuals, from none at all to significant, depending on severity and location.
Fibroids, endometrial polyps, adhesions and certain uterine abnormalities may affect fertility in some cases, largely depending on their size, number and whether they distort the uterine cavity. Many uterine findings have no effect on fertility at all.
Thyroid disorders and certain other hormonal conditions can affect ovulation and reproductive function. These are often identifiable and manageable, which is one reason evaluation is worthwhile.
Sometimes evaluation finds no clear cause. That is a genuine and common result, not a failure of the evaluation, and it does not mean nothing can be done. Treatment planning then rests on the couple’s overall picture.
As general clinical guidance: if you are younger than 35, seek evaluation after twelve months of regular unprotected intercourse without pregnancy. If you are 35 or older, after six months. Over 40, more immediate evaluation may be appropriate. These are guidelines for orientation, not rigid rules for every individual.
Some situations justify earlier evaluation regardless of the calendar: irregular or absent periods, suspected or diagnosed endometriosis, known or suspected tubal disease, other known reproductive conditions, previous chemotherapy or radiation that could affect reproductive potential, recurrent pregnancy loss, or any history that worries you enough to keep researching pages like this one. A consultation converts that worry into information, and it commits you to nothing.
A good evaluation is systematic. Professional guidance, including from ASRM, describes assessing ovulation, reproductive anatomy including tubal patency, and relevant partner factors, with testing tailored to the individual rather than a fixed panel for everyone. In practice, evaluation may include:
Menstrual cycle pattern, duration of infertility, previous pregnancies and their outcomes, previous fertility treatment, pelvic pain, abnormal bleeding, past pelvic infection or surgery, current medications, relevant medical conditions and family history. This conversation often does more diagnostic work than any single test.
A regular, predictable cycle is itself useful evidence about ovulation. Depending on circumstances, assessment may also include ovulation predictor testing, ultrasound tracking or selected blood tests. Not every patient needs all of these.
AMH, antral follicle count on ultrasound and, in selected circumstances, FSH and estradiol can be used to assess ovarian reserve. These results help guide treatment planning, particularly around ovarian stimulation. They are an adjunct to the evaluation, not a standalone verdict on fertility, and ASRM explicitly cautions against using them as a general fertility screening test.
Pelvic ultrasound, usually transvaginal, assesses the uterus, ovaries and surrounding structures, and can identify fibroids, polyps, ovarian findings and follicle counts. Further imaging may be considered when indicated.
Tests such as HSG (hysterosalpingography) or sonographic tubal assessment may be used to evaluate whether the tubes are open, when clinically indicated. Tubal assessment matters most where history raises suspicion, and before treatments that depend on tubal function.
Infertility evaluation should never focus only on the woman. Male factors contribute in a large share of couples, alone or in combination, and a semen analysis is simple to arrange. Where applicable, the male partner’s evaluation proceeds in parallel, and male infertility treatment has its own dedicated page.
For conception to happen, several things need to work together: an egg must be released, the fallopian tubes must allow egg and sperm to meet, the uterus must be able to support implantation, and the hormonal signals coordinating all of it must function. Female fertility factors are simply the points in that chain where difficulty can arise, and each has its own evaluation and its own treatment logic.
Female infertility treatment in Noida, done well, therefore never starts with a treatment. It starts with a structured evaluation: your menstrual and reproductive history, an assessment of ovulation, imaging of the uterus and ovaries where appropriate, tubal assessment when clinically indicated, and, in parallel, evaluation of the male partner, because factors often coexist. Age and reproductive history run through every part of this assessment, shaping both what is investigated and what is recommended.
Only then does female fertility treatment in Noida become a plan: addressing an identified cause where possible, supporting ovulation in selected cases, or considering assisted options such as IUI or IVF where the findings point there. The rest of this page walks through each part of that picture.
| Evaluation | What It May Help Assess |
|---|---|
| Menstrual history | Ovulation pattern and cycle regularity |
| Blood tests | Selected hormonal and reproductive factors, when indicated |
| AMH | Ovarian reserve, as an adjunct to the wider evaluation |
| Antral follicle count | Follicle quantity and ovarian reserve, via ultrasound |
| Pelvic ultrasound | Uterus, ovaries and pelvic structures |
| HSG | Uterine cavity and fallopian tube patency |
| Other targeted testing | Specific clinical concerns raised by history or findings |
No patient needs every test on this table. Your fertility specialist selects investigations based on your age, symptoms, history and earlier findings, and should be able to explain why each recommended test earns its place in your evaluation.
Conception in any cycle depends on an egg actually being released, so regular ovulation sits at the centre of natural fertility. When ovulation is irregular or absent, opportunities to conceive become fewer and far harder to time, which is why ovulatory disorders are such a common thread in fertility consultations.
Contributing factors range from PCOS to thyroid and other hormonal conditions, significant weight change and more. Because the causes differ, so do the treatments: what helps one woman ovulate regularly may be irrelevant for another. Evaluation identifies the pattern and the likely cause first, and ovulation focused treatment, where appropriate, is then chosen and supervised by the treating doctor for that individual situation.
Yes, PCOS can affect fertility, mainly by disturbing ovulation, and no, PCOS does not mean infertility. Both halves of that sentence matter.
In PCOS, hormonal imbalances can make ovulation irregular or absent, which can make conception more difficult. But the spectrum is wide: some women with PCOS ovulate and conceive without any help, others conceive once ovulation is supported, and others need further treatment. What fertility care looks like with PCOS depends on your ovulatory pattern, your wider evaluation and your goals, which is exactly what a consultation establishes. If you have a PCOS diagnosis and are planning pregnancy, an earlier conversation is reasonable, calmly and without alarm.
They help predict how the ovaries may respond to fertility treatment, particularly stimulation, and they inform planning and timing.
AMH is not a fertility score, a low result does not mean pregnancy is impossible, and a reassuring result does not guarantee conception, because egg quality, tubal function, uterine factors and partner factors all sit outside what AMH measures.
Ovarian reserve refers to the quantity of eggs remaining in the ovaries, most commonly assessed through AMH and antral follicle count. It naturally declines with age, though the pace varies between individuals, which is why two women of the same age can have quite different reserve results.
What these tests tell you is useful but specific: they help predict how the ovaries may respond to fertility treatment, particularly stimulation, and they inform planning and timing. What they do not do is measure your overall fertility. AMH is not a fertility score, a low result does not mean pregnancy is impossible, and a reassuring result does not guarantee conception, because egg quality, tubal function, uterine factors and partner factors all sit outside what AMH measures.
If a low reserve result has worried you, the right response is a conversation, not a conclusion. In treatment planning, reserve is one input among several, and options exist across the range of results.
Female fertility generally declines with age, because both the number of eggs and their quality change over time. Professional guidance, including from ACOG, describes fertility beginning to decline gradually in the early 30s and more quickly after about 37. That is population level biology, not an individual prediction: age alone cannot tell any one woman what her fertility is.
What age sensibly changes is timing. From 35, evaluation is reasonable after six months of trying rather than twelve, and over 40 it makes sense not to delay evaluation at all. Age also shapes treatment conversations, from how ovarian reserve is weighed to how quickly options are escalated. None of this calls for panic, and this page will not manufacture any. It calls for information, obtained a little earlier.
Natural conception physically happens in the fallopian tube: the egg travels from the ovary, sperm travel up to meet it, and the fertilised egg then journeys to the uterus. A blocked or damaged tube can interrupt this at any point, which is why tubal factors are a well established cause of infertility and why tubal evaluation, with tests such as HSG when clinically indicated, can be an important part of the workup.
Tubal damage has several possible origins, including previous pelvic infection, endometriosis and previous surgery. What follows depends on the location and severity of the problem and on the wider fertility assessment. Where tubal factors significantly impair natural conception, IVF treatment in Noida may be considered in selected cases, because IVF achieves fertilisation in the laboratory and the embryo is transferred directly to the uterus. Whether that path, or another, fits your situation is a specialist assessment.
Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside it, commonly causing pelvic pain and sometimes affecting fertility. The association with infertility is real but highly variable: many women with endometriosis conceive without difficulty, while for others it contributes through effects on the tubes, ovaries or pelvic environment.
Because severity, location and individual reproductive factors differ so much, there is no single endometriosis and fertility answer. Evaluation establishes what role, if any, the condition plays in your situation, and treatment planning is individualised from there, sometimes involving coordination with other specialists. If you have endometriosis and are finding conception difficult, earlier evaluation is a reasonable step.
Sometimes, and far from always. Whether a fibroid, polyp or other uterine finding matters for fertility depends mostly on its location, size, number and whether it distorts the uterine cavity where an embryo would implant. Many fibroids sit where they have no fertility effect at all, and are simply findings.
This is why appropriate imaging, usually pelvic ultrasound with further assessment when indicated, is the honest way to answer the question for your uterus rather than anyone’s in general. If a finding is judged relevant, the options, which can include treatment by an appropriately qualified specialist, are discussed as part of your individual plan.
Treatment depends on the underlying cause, age, reproductive history and the fertility findings of both partners. There is no single female infertility treatment, and a plan that ignores any of those inputs is not a plan.
IUI may be considered in selected circumstances: some ovulation related infertility, particularly in plans where ovulation is being supported and timed; unexplained infertility; and selected cases where tubal function is adequate and the overall assessment favours a simpler first step. Adequate tubal function is a genuine precondition, since IUI still relies on egg and sperm meeting in the tube, which is why IUI is not appropriate where tubes are blocked. How the procedure works, cycle by cycle, is covered on the page about IUI treatment in Noida, and whether it fits your findings is a consultation decision.
Adequate tubal function is a genuine precondition.
A precise one, and it is worth being exact: ICSI is a laboratory fertilisation technique used within IVF, in which a single sperm is injected directly into a mature egg. When ICSI is added to a cycle, the reason usually relates to sperm parameters or previous fertilisation problems, not to the female diagnosis itself.
So ICSI does not treat female infertility; it addresses the fertilisation step when that step needs direct help. If your treatment plan includes it, the reasoning should be explained, and the technique itself is covered on the page about ICSI treatment in Noida.
IVF earns consideration where the findings point to it: blocked or damaged fallopian tubes, certain endometriosis related infertility, some ovulatory and ovarian factors that have not responded to simpler approaches, age related considerations where time carries weight, unexplained infertility after other options, and male factor infertility within the couple. No single diagnosis makes IVF automatic, and a good specialist will explain why it is, or is not, the right tool for your situation. The full treatment, from stimulation to embryo transfer, is explained on the IVF page rather than repeated here.
Because infertility is a couple level picture: it can involve female factors, male factors, both together, or no identifiable cause. Evaluating only one partner risks months of investigation and treatment aimed at half the picture, and it quietly places the weight of the situation on one person, which is neither fair nor accurate.
Evaluating both partners early avoids that delay. The male evaluation usually begins with a simple semen analysis, and male infertility treatment has its own page for everything that follows from it. At a practical level, couples who are evaluated together also decide together, and treatment plans hold up better that way.
From 35, the guidance shifts in one practical way: evaluation is reasonable after six months of trying rather than twelve. Fertility generally declines with age, so information gathered earlier keeps more options open, and treatment planning from 35 onward weighs ovarian reserve and timing somewhat more heavily.
What does not change is the logic of care. Evaluation still comes first, treatment still follows the findings, and the right plan may still be the simplest one. Being 35, or 38, does not itself place anyone on a conveyor belt to any particular treatment, and individual circumstances, not the birthday, decide the recommendation.
Over 40, the sensible adjustment is simply not to delay evaluation. Egg quantity and quality generally decline with age, and the time spent waiting on a twelve month rule serves no one at this stage. An early, thorough assessment, ovarian reserve, tubal and uterine evaluation where indicated, and partner factors, gives an honest starting point.
Treatment options after 40 depend on that assessment: ovarian reserve, reproductive history, partner findings and your own preferences all shape what is realistic and what is wise. Pregnancy after 40 is not impossible, and no responsible clinic will tell you it is guaranteed either. What you should expect from a consultation at this stage is speed, candour and a plan that respects both.
To a modest, honest extent, yes. Guidance from bodies such as ACOG notes that being significantly underweight or overweight, excessive exercise, smoking and moderate to heavy alcohol use can affect fertility in some women. Maintaining a generally healthy weight, not smoking, limiting alcohol and managing chronic conditions are all reasonable steps that support reproductive health, and they cost nothing.
The boundary matters as much as the advice. No specific food boosts fertility, no detox or supplement guarantees pregnancy, and no lifestyle change reverses age related changes in eggs. If you take regular medication, review it with your clinician rather than stopping anything on your own. Lifestyle is the supporting cast; evaluation and, where needed, treatment remain the plot.
Fertility evaluation and treatment ask a lot: waiting, testing, uncertainty, and conversations that touch the most personal parts of life. Finding it hard is not weakness, and it is common. Two things are worth saying plainly. Stress does not cause infertility, so no one should carry blame for feeling what they feel. And support helps, whether from a partner, trusted people, or professional counselling when the weight becomes heavy. Raise it at consultation if you are struggling; caring for the person going through treatment is part of caring for the treatment.
No single number describes outcomes for female infertility, because results depend on several factors working together:
Because these interact, outcome conversations belong after evaluation, framed individually and honestly. No clinic can promise pregnancy, and this page will not pretend otherwise.
Because treatment follows the cause, costs vary widely between patients. The elements that shape the total include:
Not every element applies to every patient, which is why female infertility treatment cost in Noida has no single honest figure. Ask for written, individualised cost information for your specific plan at consultation, before treatment begins, and again whenever the plan changes.
Treatment plans deserve review points, agreed in advance. IVF may enter the conversation when IUI has not resulted in pregnancy after an appropriate course of treatment, when age or fertility findings suggest a different approach would serve better, when tubal factors make IUI unsuitable in the first place, or when other clinical factors point that way. There is no universal number of IUI cycles that fits everyone; the decision weighs age, diagnosis, ovarian reserve, partner factors and your own preferences. What matters is that moving on is a considered decision made with your specialist, and the IVF page explains what that next step involves.
A calm discussion of your fertility history, your questions and what you want from care.
Assessment of ovulation, ovarian reserve, uterus and tubes as indicated, with the male partner evaluated in parallel.
Understand what may be affecting conception, or establish that no clear cause is found.
An appropriate pathway chosen from your findings, from addressing a cause to IUI or IVF where indicated.
Progress reviewed at agreed points, with the plan adjusted when clinically appropriate.
The sequence is a framework, not a fixed pathway for every patient.
Book a ConsultationDr. Shuchi Rastogi IVF & Infertility Specialist
Female infertility treatment is one of the six approved treatment areas at Follicles IVF & Fertility Clinic, D 194, Sector 10, Noida. Care begins with a consultation with Dr. Shuchi Rastogi, IVF & Infertility Specialist: your history heard properly, an evaluation planned around it, and findings explained in plain language, including what they do not show.
Treatment recommendations then follow the evaluation. For some patients that means addressing an identified factor. For others it means IUI, or IVF, with ICSI where fertilisation needs direct help, and the reasoning is explained at each step. Because the clinic’s fertility care also spans male infertility treatment and fertility preservation, the couple’s whole picture stays in one conversation, and nobody is handed a treatment before the evaluation has earned it.
To know the doctor leading your care, meet Dr. Shuchi Rastogi. To begin, call or WhatsApp +91 92052 12727.
Female infertility means difficulty achieving pregnancy related to factors affecting the female reproductive system, such as ovulation problems, ovarian reserve, tubal or uterine factors, or age related changes. Infertility can involve female factors, male factors, both or no identifiable cause, which is why both partners are usually evaluated together.
Common contributors include ovulation problems (with PCOS a frequent factor), reduced ovarian reserve, age related changes in egg quantity and quality, blocked or damaged fallopian tubes, endometriosis, uterine findings such as some fibroids and polyps, and hormonal conditions such as thyroid disorders. In a meaningful share of couples, evaluation finds no clear cause at all.
As general guidance: after twelve months of trying if you are under 35, after six months if you are 35 or older, and without delay over 40. Go earlier with irregular or absent periods, suspected endometriosis or tubal disease, other known reproductive conditions, previous chemotherapy or radiation, or recurrent pregnancy loss.
Evaluation is tailored to the individual and may include menstrual and reproductive history, ovulation assessment, ovarian reserve testing such as AMH and antral follicle count, pelvic ultrasound, and tubal assessment such as HSG when clinically indicated, alongside evaluation of the male partner. No one needs every test; your specialist selects what your history and findings justify.
PCOS can affect fertility, mainly by making ovulation irregular or absent, which can make conception more difficult. It affects individuals very differently: many women with PCOS conceive naturally, others conceive once ovulation is supported, and others need further treatment. A fertility evaluation establishes what, if anything, PCOS means for your situation.
Low ovarian reserve means fewer eggs remain, which is relevant to fertility treatment planning and to how the ovaries may respond to stimulation. On its own it does not mean pregnancy is impossible, and it is not a standalone diagnosis of infertility. It is one input in the overall assessment, weighed alongside age, tubal, uterine and partner factors.
No. AMH helps assess ovarian reserve, which is useful for planning fertility treatment, but ovarian reserve is not the same thing as overall fertility. A low AMH does not mean you cannot conceive, and a reassuring AMH does not guarantee conception, because egg quality, tubal function, uterine and partner factors sit outside what AMH measures.
Yes. Egg and sperm normally meet in the fallopian tube, so a blocked or damaged tube can prevent fertilisation. Tubal problems can follow pelvic infection, endometriosis or surgery. Where tubal factors significantly impair natural conception, IVF may be considered in selected cases, since fertilisation then happens in the laboratory.
Endometriosis can be associated with infertility, but its impact varies widely between individuals. Many women with endometriosis conceive without difficulty, while for others it contributes through effects on the tubes, ovaries or pelvic environment. Evaluation establishes what role it plays in your situation, and treatment planning is individualised from there.
In IUI, prepared sperm is placed into the uterus and fertilisation happens naturally inside the body, so it suits selected, generally milder situations with adequate tubal function. In IVF, eggs are retrieved and fertilised in a laboratory and an embryo is transferred to the uterus, which is why it is considered for a broader range of causes, including tubal factors.
IVF may be considered for blocked or damaged tubes, certain endometriosis related infertility, some ovulatory and ovarian factors, age related considerations, unexplained infertility, or male factor infertility within the couple. No single diagnosis makes IVF automatic; the recommendation follows the couple’s complete evaluation and is explained at consultation.
Cost follows the treatment plan, which follows the cause: consultation and evaluation of both partners, the diagnostic tests your situation justifies, monitoring, medication where clinically appropriate, and assisted treatment such as IUI or IVF where chosen. No single figure applies to everyone, so ask for written, individualised cost information at consultation before you begin.
Understanding what is affecting conception is the first real step, and it is a manageable one: a conversation, a considered evaluation and findings explained honestly. From there, treatment is a decision you make with clear information, at your own pace, whether the answer is addressing a specific factor, IUI, IVF or simply knowing more than you did. Book a consultation with Dr. Shuchi Rastogi when you are ready. No pressure, and no obligation to proceed.
